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The N-terminal domains of the NS1 protein of influenza B virus (NS1B protein) and the NS1 protein of influenza A virus
(NS1A protein) share one function: binding double-stranded RNA (dsRNA). Here we show that the N-terminal domain of the
NS1B protein possesses an additional function that is not shared by its NS1A counterpart: binding the ubiquitin-like ISG15
protein that is induced by influenza B virus infection. Homology modeling predicts that the dimeric six-helical N-terminal
domain of the NS1B protein differs from its NS1A protein counterpart in containing large loops between helices 1 and 2
(loops 1 and 1) and between helices 2 and 3 (loops 2 and 2). Mutagenesis establishes that residues located in loop 1/1
together with residues located in polypeptide segment 94–103 form the ISG15 protein-binding site of NS1B protein. Loop 1/1
is not required for dsRNA binding, which instead requires arginine residues R50, R53, R50, and R53 located in antiparallel
helices 1 and 1. Further, we demonstrate that the binding sites for RNA and protein are independent of each other. In
particular, ISG15 and dsRNA can bind simultaneously; the binding of the ISG15 protein does not have a detectable effect on
the binding of dsRNA, and vice versa. © 2002 Elsevier Science (USA)modeling; RNA–protein interactions; protein–protein intera
INTRODUCTION
Influenza A and influenza B viruses, two of the four
influenza virus genera, cause widespread epidemics in
humans (Lamb and Krug, 2001; Wright and Webster,
2001). Both of these influenza viruses contain eight
genomic RNA segments, and most of the proteins en-
coded by the corresponding genomic RNA segments
serve similar functions (Lamb and Krug, 2001). One major
difference between these two influenza viruses is the
biological activity of their nonstructural (NS1) proteins.
The NS1 protein of influenza A virus (NS1A protein), but
not the NS1 protein of influenza B virus (NS1B protein),
binds and inhibits the function of two cellular proteins
that are required for the 3 end processing of cellular
pre-mRNAs: the 30-kDa subunit of the cleavage and
polyadenylation specificity factor (CPSF) and poly(A)-
binding protein II (PABII) (Nemeroff et al., 1998; Chen et
al., 1999; Chen and Krug, 2000). The binding sites for
these cellular proteins are near the C-terminal end of the
237 amino acid long NS1A protein: the 30-kDa CPSF
1 To whom correspondence and reprint requests should be ad-
dressed at Institute for Cellular and Molecular Biology, University of291subunit binding site is centered around amino acid 186
and the PABII binding site is located in the 223–237
amino acid region (Li et al., 2001) (Fig. 1). As a result of
the inhibition of 3 end processing, newly synthesized
cellular mRNAs are not exported from the nucleus after
influenza A virus infection (Chen et al., 1999; Shimuzu et
al., 1999). Conversely, the NS1B protein, but not the NS1A
protein, binds ISG15, an ubiquitin-like protein that is
induced by influenza B virus (Yuan and Krug, 2001). This
binding results in inhibition of the conjugation of ISG15 to
its target proteins.
Despite these differences, the NS1A and NS1B pro-
teins possess similar RNA-binding properties (Wang and
Krug, 1996). The RNA-binding domain is located at the
N-terminus of both the NS1A and the NS1B proteins (Fig.
1), and its primary RNA target is double-stranded RNA
(dsRNA) (Hatada and Fukuda, 1992; Lu et al., 1995; Wang
et al., 1999). The three-dimensional structure of the RNA-
binding domain of the NS1A protein, which comprises its
73 N-terminal amino acids, has been determined (Chien
et al., 1997; Liu et al., 1997). Each monomer is comprised
of three -helices, which are connected by two short
turns. This domain exhibits a novel dimeric six-helical
chain fold that differs from that of any other knownKey Words: influenza B virus; influenza A virus; influenza v
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lular proteins (Chien et al., 1997; Liu et al., 1997; Ryter
and Schultz, 1998; Cusack, 1999; Ramos et al., 2000;
Perez-Canadillas and Varani, 2001).
Mutagenesis experiments have established that the
dimer structure of the NS1A RNA-binding domain is re-
quired for RNA binding (Wang et al., 1999). In addition,
these experiments showed that only two basic amino
acids in each of antiparallel helices 2 and 2 (R at
position 38/38 and K at position 41/41) are required for
RNA binding, but not for protein dimerization, indicating
that these basic amino acids probably interact directly
with the dsRNA target. The data support a model in
which helices 2 and 2 of the RNA-binding domain are
aligned with, and span, the minor groove of A form
dsRNA, with electrostatic contacts between one or both
R38 and K41 in helices 2 and 2 and the polyphosphate
backbone of the RNA (Chien et al., 1997; Wang et al.,
1999).
The three-dimensional structure of the RNA-binding
domain of the NS1B protein, which is 93 amino acids in
length and thus 20 amino acids larger than that of the
NS1A protein, has not yet been determined. Nonethe-
less, sequence alignment of the RNA-binding domains of
the NS1A and NS1B proteins suggested that the RNA-
binding domain of the NS1B protein exhibits a dimeric
six-helical chain fold similar to that of the NS1A protein,
except that there are large loops between the three 
helices in each chain (Wang et al., 1999).
An additional role for the NS1B RNA-binding domain
has been suggested by previous experiments. The bind-
ing of the ubiquitin-like ISG15 protein by the NS1B pro-
tein requires its N-terminal 103 amino acids, which in-
cludes the RNA-binding domain (the N-terminal 93 amino
acids) as well as the adjacent 94–103 region (Yuan and
Krug, 2001) (Fig. 1). Two possible reasons that the RNA-
binding domain is required for the binding of ISG15 were
postulated: this region is required for the dimerization,
and hence the proper folding, of the NS1B protein; and/or
specific amino acids in this domain interact directly with
the ISG15 protein.
Here we describe homology modeling and results of
mutagenesis of the RNA-binding domain of the NS1B
protein. We establish that the RNA-binding domain of the
NS1B protein does contain part of the binding site for the
ISG15 protein and that this site is located in one of the
predicted surface loops of this domain. In addition, we
show that, as predicted by both sequence alignment and
homology modeling, residues R50, R53, R50, and R53 of
the NS1B protein are required for dsRNA binding, but not
for protein dimerization, strongly suggesting that these
four basic residues interact directly with the dsRNA tar-
get. Further, we demonstrate that the N-terminal NS1B-
binding sites for RNA and protein are independent of
each other. Thus, ISG15 and dsRNA can bind to the
N-terminal 103 amino acid long fragment of the NS1B
protein (NS1B(1-103)) simultaneously, the binding of the
ISG15 protein to this domain does not have a detectable
effect on the binding of dsRNA, and vice versa. These
results establish that the N-terminal region of the NS1B
protein binds not only dsRNA but also a specific cellular
protein and thus differs from the corresponding region of
the NS1A protein, which appears to function solely as a
dsRNA-binding domain.
RESULTS
Previously we showed that NS1B(1-103), the N-termi-
nal 103 amino acid domain of the NS1B protein of influ-
enza B virus, binds the ISG15 protein as efficiently as the
full-length NS1B protein (Yuan and Krug, 2001). Both the
94–103 region and the RNA-binding domain (the N-ter-
minal 93 amino acids) are required for ISG15 binding.
One of our major goals is to determine the role of the
N-terminal, 93 amino acid RNA-binding domain (NS1B(1-
93)) in ISG15 binding, i.e., whether it is required because
it maintains the dimerization, and hence proper folding,
of the NS1B protein, or whether it contains part of the
binding site for the ISG15 protein.
Homology modeling of the RNA-binding domain of the
NS1 B protein (NS1B(1-93))
As a framework for this analysis, we generated a
homology model of the three-dimensional structure of
the NS1B(1-93) RNA-binding domain. The modeling was
carried out by homology-constrained target function op-
timization using the program DYANA (Guntert et al., 1997)
and homology modeling algorithms that have been de-
scribed previously (Li et al., 1997; Sahasrabudhe et al.,
1998). This model is based on the known NMR solution
structure of the NS1A(1-73) RNA-binding domain (Chien
FIG. 1. The binding sites of cellular proteins on the domains of the NS1A and NS1B proteins. Amino acid residue numbers are denoted.
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et al., 1997) and a sequence alignment of NS1A(1-73) and
NS1B(1-93) reported earlier (Wang et al., 1999), which is
reproduced in Fig. 2. A total of 3268 homology con-
straints were used to generate 20 conformers, each
satisfying these homology and steric constraints about
equally well. The principal determinants of this model
are (i) the proposed sequence alignment of NS1B(1-93)
against the sequence of NS1A(1-73), (ii) conformer 1 from
the solution NMR structure of NS1A(1-73) (Chien et al.,
1997), and (iii) standard bond lengths, bond angles, and
steric energy features that are defined within the DYANA
program (Guntert et al., 1997). The resulting structures
satisfy all of the homology constraints and steric con-
straints of the DYANA target function. This predicted
model should be taken as an interpretation of the impli-
cations of the proposed sequence alignment in terms of
overall dimeric chain fold, but not necessarily an accu-
rate description of the details of the atomic structure.
The predicted structure of the RNA-binding domain of
the NS1B protein (NS1B(1-93)) (Figs. 3 and 4) exhibits a
dimeric six-helical chain fold similar to that of the NS1A
protein (NS1A(1-73)). The large surface loops between
the -helices in the NS1B(1-93) model (shown in red in
Fig. 3) contain 21 amino acids residues that are absent
from NS1A(1-73). Because these loops appear as inser-
tions in the sequence alignment (Fig. 2), these amino
acids are left unconstrained in the structure calculations,
so that our homology modeling approach does not pre-
dict a specific structure for these loops (Fig. 3). They may
in fact be disordered, as suggested by the multiple con-
formations adopted by these loops in the set of models.
Alternatively, these loops may be ordered with a specific
conformation that cannot be predicted from available
information.
As can be seen in the ribbon representations of the
predicted three-dimensional structure of NS1B(1-93)
shown in Figs. 3 and 4, loop 1 (residues 24–36) of
polypeptide chain 1 is located between the N- and C-
termini (N and C), respectively, of the other polypeptide
chain, chain 2. By symmetry, loop 1 of chain 2 is located
between N- and C-termini of chain 1. In contrast, loop 2
(residues 64–71) of polypeptide chain 1 is located near
the N-terminus of the same chain (N), and by symmetry
loop 2 of chain 2 is located near the N-terminus (N) of
chain 2. The model (Fig. 4) also predicts that two basic
residues from each monomer (R50, R53, and R50, R53)
mediate the binding of dsRNA, as is the case for their
counterparts in the homologous NS1A RNA-binding do-
main (R38, K41 and R38, K41) (Wang et al., 1999).
Identification of an ISG15-binding site in the RNA-
binding domain of the NS1B protein
Based on this model, we hypothesized that one or both
of the large loops in the NS1B RNA-binding domain
comprises part of the binding site(s) for the ISG15 pro-
tein. To determine whether this is the case, we intro-
duced the following mutations into the NS1B(1-103) do-
main that binds both ISG15 and dsRNA (Fig. 5A): alanine
replacements for three amino acids (E29, Y31, and R33)
in the loop between helices 1 and 2 (loop 1/1 mutant); a
deletion of six amino acids (amino acids 65–70) from the
loop between helices 2 and 3 (loop 2/2 mutant); and, as
a control, alanine replacements for R50, R53 and R50,
R53 (R50/R53 mutant). To measure ISG15-protein bind-
ing, each of these mutant proteins (labeled in vitro) was
mixed with purified GST-tagged ISG15 protein, and the
mixtures were selected on glutathione-Sepharose beads
(Fig. 5B). Of these mutant proteins, only the loop 1 mutant
fails to bind the ISG15 protein. This result, coupled with
that described below, indicates that each loop 1 com-
prises part of the ISG15 protein-binding site.
The arginines at positions 50 and 53 (R50, R53)
are required for dsRNA-binding, but not for
protein dimerization
To identify the amino acids that are required for bind-
ing dsRNA, we carried out gel shift assays using a
radiolabeled 200-base-pair dsRNA as the RNA target
(Fig. 6A). The loop 1/1 mutation does not detectably
reduce the dsRNA-binding activity of the NS1B(1-103)
protein (compare Lanes 2 and 4). Consequently, this
mutation specifically eliminates ISG15 binding without
affecting dsRNA binding. In contrast, as predicted by the
model of the NS1B(1-93) structure shown in Figs. 3 and
4, replacement of R50, R53 and R50, R53 with alanines
(R50/R53 mutant) results in the loss of RNA-binding ac-
tivity (Fig. 6A, Lane 3), without affecting ISG15 binding
(Fig. 5B, Lane 4). These results demonstrate that ISG15-
protein binding does not require the R50, R53 and R50,
R53 residues that are necessary for dsRNA binding, and
dsRNA binding does not require the loop 1/1 amino acid
residues that are necessary for ISG15 protein binding.
Because the dimer structure of the RNA-binding do-
main of the NS1A protein is required for dsRNA binding
(Wang et al., 1999), it was possible that the R50/R53
mutation of the NS1B RNA-binding domain resulted in a
loss of dsRNA-binding activity because the mutant pro-
tein does not form the native dimeric structure. To deter-
mine whether the R50/R53 mutant NS1B(1-103) protein,
similar to the wild-type protein, is in the form of a dimer,
the two proteins were treated with the crosslinking re-
agent glutaraldehyde, and the untreated and treated pro-
teins were analyzed by electrophoresis on a denaturing
gel (Nemeroff et al., 1995) (Fig. 6B). After glutaraldehyde
treatment, a large fraction of both the mutant and the
wild-type NS1B(1-103) proteins migrated as a dimer. The
dimer form was consistently a major species of both the
mutant and the wild-type NS1B(1-103) proteins after glu-
taraldehyde treatment, although the ratio of dimer to
monomer varied between different experiments. Thus,
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FIG. 2. Sequence alignment of the RNA-binding domains of NS1A(1-73) and NS1B(1-93) (Wang et al., 1999), based on the Bestfit program of GCG.
The three -helices in NS1A(1-73) as well as the insertions in NS1B(1-93) are indicated. Identical residues (20%) are shaded in orange while
conserved residues (20%) are shaded in yellow.
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FIG. 3. Stereo pairs showing an ensemble of nine conformers representing the predicted three-dimensional structure of the NS1B(1-93)
RNA-binding domain. These homology models are based on the NMR structure of the NS1A(1-73) RNA-binding domain (Chien et al., 1997) and the
sequence alignment shown in Fig. 2. The backbone representation of residues (14 in number) that are identical between NS1B(1-93) and NS1A(1-73)
are depicted in green; blue designates amino acids in the NS1B(1-93) structure that are not identical (14 of these are similar amino acids), but are
within the alignment; red designates 21 additional amino acids that are in NS1B(1-93) but not in NS1A(1-73). The three helices in each polypeptide
chain are shown as ribbons, and the dsRNA-binding site in NS1A(1-73) is indicated. The stereo pairs designated (A) and (B) are the same ensemble
of nine conformers rotated by 90o around the horizontal axis.
FIG. 4. Ribbon diagrams of the NS1(1-73) NMR structure (A, C) and of the NS1B(1-93) homology model (B, D). The pairs designated A, B, and C,
D, respectively, are the same structures rotated by 90o around the horizontal axis. The individual polypeptide chains in each dimer are colored
magenta (chain 1) and cyan (chain 2). The RNA-binding residues R50 and R53 in NS1B(1-93), and their analogs in NS1A(1-73) (i.e., R38 and K41), are
shown in green. The loop 1/1 mutations and loop 2/2 deletions in NS1B(1-93) are shown in yellow and orange, respectively.
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the R50/R53 NS1B mutant protein is similar to the R38/
K41 NS1A mutant protein, i.e., loss of RNA-binding activ-
ity but retention of dimerization. We conclude that R50/
R53 in both monomers of the NS1B RNA-binding domain
probably interact directly with the dsRNA target, as was
previously concluded for R38/K41 in the NS1A RNA-
binding domain (Wang et al., 1999).
The dsRNA- and ISG15-binding sites in NS1B(1-103)
are independent of each other
Although different amino acids are required for the
binding of dsRNA and ISG15, the two binding sites are in
close proximity. Consequently, it might be predicted that
the binding of either of these molecules to NS1B(1-103)
would affect the binding of the other species. To deter-
mine whether this is the case, labeled NS1B(1-103) was
incubated with an excess (10 g) of dsRNA, and its
ability to bind to GST-tagged ISG15 protein was com-
pared to that of NS1B(1-103) that had not been incubated
with dsRNA (Fig. 7A). Incubation with dsRNA does not
detectably affect the binding of NS1B(1-103) to GST-
ISG15 (compare Lanes 2 and 3).
To determine whether the binding of the ISG15 protein
to NS1B(1-103) affects its dsRNA-binding activity, we
preincubated NS1B(1-103) with ISG15 (1:2 molar ratio)
and then compared the RNA-binding activity of the re-
sulting complex to that of uncomplexed NS1B(1-103) (Fig.
7B). At the concentration of NS1B(1-103) employed in this
experiment (400 nM), NS1B(1-103) in the absence of
ISG15 binds all the radiolabeled 200-base-pair dsRNA
(1.5 nM), as assayed by gel shift (compare Lanes 1 and
2). The complex containing NS1B(1-103) and ISG15 also
binds all the radiolabeled dsRNA (Lane 3). The resulting
RNA–protein complex has a lower mobility during gel
electrophoresis than the RNA–protein complex formed
with NS1B(1-103) alone (compare Lanes 2 and 3), indi-
cating that the ISG15 protein remains associated with
NS1B(1-103) in the dsRNA–protein complex.
FIG. 5. (A) The mutations introduced into the NS1B(1-103) protein. (B) Loop 1/1, but not loop 2/2 or R50/R53, comprises part of the ISG15
protein-binding site. GST-ISG15 (1 g) was added to each of the following 35S-labeled NS1B(1-103) proteins: wild-type (Lane 1), loop 1/1 mutant (Lane
2), loop 2/2 mutant (Lane 3), or the 50/53 mutant (40,000 cpm each). The mixtures were subjected to glutathione-Sepharose affinity selection, and
the eluted proteins were analyzed by electrophoresis on a 12% SDS–polyacrylamide gel. The doublets seen with all the NS1B(1-103) proteins were
present both before and after the binding assay, indicating that they were generated during in vitro translation.
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To determine whether the binding of the ISG15 protein
changes the affinity of NS1B(1-103) for its dsRNA target,
we carried out dsRNA-binding assays at various concen-
trations of NS1B(1-103) (ranging from 25 to 800 nM) in the
absence and presence of the ISG15 protein (Fig. 7C). The
ratio of NS1B(1-103) to ISG15 was maintained at 1:2 at all
concentrations of NS1B(1-103). In both the absence
(Lanes 2–7) and the presence (Lanes 8–13) of the ISG15
protein, dsRNA binding is detected at 100 nM NS1B(1-
103), and all the radiolabeled dsRNA binds at 200 nM
NS1B(1-103). Consequently, the binding of ISG15 to
NS1B(1-103) does not have a detectable effect on the
affinity of NS1B(1-103) for dsRNA.
DISCUSSION
Our results show that the N-terminal domain of the
NS1B protein of influenza B virus binds not only dsRNA,
but also the ISG15 protein. The NS1B(1-103) dimeric
domain, which has a molecular weight of approximately
22.7 kDa, binds both a protein of comparable molecular
weight, the ISG15 protein (17.3 kDa), and a large (200
base pair) dsRNA. Thus, this domain should be desig-
nated as a RNA/protein interaction domain. In contrast, a
protein-binding site has not been identified in the com-
parable N-terminal region of the NS1A protein of influ-
enza A virus, indicating that this region of the NS1A
protein likely functions solely as an RNA-binding domain.
Our results thus establish that the divergence of the
NS1A and NS1B proteins results in differences in the
functions of not only their effector domains but also their
N-terminal domains.
The binding of the ISG15 protein to the N-terminal
region of the NS1B protein is mediated by two amino
acid sequences: (i) in the 94–103 region (Yuan and Krug,
2001); and (ii) in loop 1/1, the large loop between helices
1 and 2 in each of the monomers (present study). Be-
cause two copies of loop 1 are present in the NS1B(1-
103) dimer, it is likely that two ISG15 protein molecules
bind to each NS1B(1-103) dimer. Thus, the presence of
FIG. 6. (A) R50/R53, but not loop 1/1, is required for binding dsRNA.
Radiolabeled dsRNA (1.5 nM) was mixed with each of the following
NS1B(1-103) proteins at 400 nM: wild-type (Lane 2), 50/53 mutant (Lane
3), loop 1/1 mutant (Lane 4). Lane 1: dsRNA alone. The samples were
analyzed by non-denaturing electrophoresis. (B) R50/R53 is not re-
quired for dimerization. Purified wild-type (Lanes 1 and 2) or 50/53
mutant (Lanes 3 and 4) NS1B protein, either untreated (Lanes 1 and 3)
or treated with 0.01% glutaraldehyde (Lanes 2 and 4), were subjected to
SDS–polyacrylamide gel electrophoresis, and the NS1 protein was
detected by immunoblotting with anti-NS1 antibody. Molecular weights
(kDa) are denoted on the right.
FIG. 7. (A) The binding of dsRNA to NS1B(1-103) does not affect its
ability to bind ISG15. GST-ISG15 (1 g) was added to 35S-labeled
NS1B(1-103) protein alone (Lane 2), or to 35S-labeled NS1B(1-103)
protein that had been preincubated with 10 g of reovirus dsRNA. Lane
1: GST added to 35S-labeled NS1B(1-103) protein alone. After glutathi-
one-Sepharose affinity selection, the eluted proteins were analyzed by
electrophoresis on a 12% SDS–polyacrylamide gel. (B) The ISG15
protein and dsRNA can bind to the NS1B(1-103) domain simulta-
neously. Radiolabeled dsRNA (1.5 nM) was incubated with either
NS1B(1-103) (400 nM) alone (Lane 2) or a mixture containing NS1B(1-
103) (400 nM) and ISG15 (800 nM) (Lane 3). Lane 1: dsRNA alone. The
samples were analyzed by non-denaturing electrophoresis. (C) The
binding of ISG15 to NS1B(1-103) does not have a detectable effect on
its affinity for dsRNA. Radiolabeled dsRNA (1.5 nM) was mixed with the
indicated concentrations of NS1B(1-103) alone (Lanes 2–7), or with
mixtures containing the indicated concentrations of NS1B(1-103) and
ISG15 (at twice the concentration of NS1B(1-103)) (Lanes 8–13). Lane 1:
dsRNA alone. The samples were analyzed by non-denaturing electro-
phoresis.
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loop 1/1 in the NS1B RNA-binding domain enables the
NS1B protein to carry out a biological function—the
inhibition of ISG15 conjugation—that is not carried out
by the NS1A protein whose RNA-binding domain lacks
loops 1/1. ISG15 binding to the N-terminal region of the
NS1B protein does not require loops 2/2, the loops
between helices 2 and 3 in each monomer, indicating
that the two surfaces of the NS1B(1-103) dimer that
contain the loop 2 sequences are not included in the
binding sites for ISG15 protein molecules (see Figs. 3
and 4).
Neither the 94–103 sequence nor loop 1 is required for
the binding of dsRNA, which instead requires the two
arginines at 50 and 53 in both monomers. These argi-
nines presumably serve the same function as their coun-
terparts in the RNA-binding domain of the NS1A protein
(R38 and K41 in NS1A(1-73)) (Wang et al., 1999), i.e.,
these two basic amino acids likely establish electrostatic
contacts with the phosphodiester backbone of the
dsRNA. These two arginines in NS1B(1-103) are not re-
quired for the binding of the ISG15 protein, demonstrat-
ing that the amino acids that are required for the binding
of dsRNA differ from those that are required for the
binding of the ISG15 protein.
Furthermore, we have shown that the ISG15 protein
and dsRNA can bind to the NS1B(1-103) domain simul-
taneously, and that the binding of the ISG15 protein does
not affect the binding site for dsRNA, and vice versa.
Hence, the NS1B(1-103) domain possesses adjacent
binding sites for RNA and protein that are independent of
each other. As can be seen in the structures shown in
Figs. 3 and 4, the ISG15-binding epitope of NS1B(1-103),
consisting of residues in loops 1/1 together with resi-
dues in the polypeptide sequence 94–103 (which if
shown on this model of NS1B(1-93) would extend from
the C-termini of chains 1 and 2, labeled C and C, re-
spectively), involves two regions that are discontinuous
in the polypeptide sequence but nearby one another in
the three-dimensional structure. In fact, the homology
model predicts that each of these two ISG15-binding
epitopes comprised residues contributed from each of
the two polypeptide chains: one of these epitopes com-
prises polypeptide segment 94–103 of chain 1 and loop
1 of chain 2; and the second includes polypeptide seg-
ment 94–103 of chain 2 and loop 1 of chain 1. Based on
our homology-modeled structure of NS1B(1-93), these
two ISG15-binding epitopes are predicted to remain sol-
vent accessible and available for potential interactions
with protein partners even when the dsRNA-binding site
of NS1B(1-93) is bound to dsRNA. These unique insights
are specific results interpretable from combined analysis
of our biochemical data and homology model.
One potential criticism of our homology model, based
on the alignment shown in Fig. 2, is that there is limited
sequence identity between the polypeptide segment
comprising helix 1 of NS1A(1-73) and the corresponding
aligned polypeptide sequence in NS1B(1-93). Although
this proposed helix 1 segment of NS1B(1-93) shows
hydrophobic periodicity characteristic of an -helix, we
cannot exclude the possibility that the corresponding
helical region in the actual structure of NS1B(1-93) is
shifted up or down along the sequence, or that it is a bit
shorter or longer than predicted. As a result, the actual
length of loops 1/1 could in fact be somewhat shorter or
longer than shown in our homology model. However, this
uncertainty in the predicted structure of NS1B(1-93) does
not change our overall conclusion that the mutations
which affect ISG15 binding map to a surface exposed
loop, which is located structurally near the C-terminal
polypeptide segment 94–103 in the NS1B(1-103) protein.
To our knowledge, no other eukaryotic RNA-binding
domain has been shown to possess independent RNA-
and protein-binding sites. These other eukaryotic RNA-
binding proteins have a modular structure and may con-
tain not only RNA-binding domains but also separate
protein-binding domains (Cusack, 1999; Perez-Canadil-
las and Varani, 2001). In contrast, some of these eukary-
otic RNA-binding domains can by themselves also inter-
act with a protein. For example, the N-terminal RNA-
binding domain (two RNA-recognition motifs, or RRMs,
connected by a short linker) of poly(A)-binding protein
binds not only poly(A) but also the translation initiation
factor eIF4G (Imataka et al., 1998; Deo et al., 1999).
However, these two binding sites do not appear to be
independent (Tarun and Sachs, 1996; Le et al., 1997;
Imataka et al., 1998).
Because the binding sites for dsRNA and ISG15 are
independent, the N-terminal domain of the NS1B protein
is capable of binding both the dsRNA and the ISG15
protein, either simultaneously or at different times during
influenza B virus infection. The binding of ISG15 to the
N-terminal domain of the NS1B protein results in the
inhibition of the conjugation of ISG15 to its target pro-
teins both in vitro and in influenza B virus-infected cells
(Yuan and Krug, 2001). The ISG15 protein is one of the
cellular proteins that is induced by influenza B virus
infection (Yuan and Krug, 2001; Kim et al., 2002). The
synthesis of these cellular proteins results from the in-
terferon-/ (IFN-/)-independent activation of the tran-
scription of cellular genes under the control of IFN/-
stimulated response elements (ISREs) (Kim et al., 2002).
Some of the proteins encoded by these genes have
antiviral activities that can protect initially infected cells
against virus replication (Boyle et al., 1999; Chin and
Cresswell, 2001; Simmen et al., 2001; Kim et al., 2002). It
is not known how influenza B virus counters the early
IFN-/-independent antiviral response of cells. It is pos-
sible that one of the influenza B virus countermeasures
results from the inhibition of the conjugation of ISG15
conjugation by the NS1B protein (Yuan and Krug, 2001;
Kim et al., 2002). To assess this possibility, it will be
necessary to identify the protein targets of ISG15 conju-
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gation and to determine how ISG15 conjugation affects
the activities of these target proteins.
Although the in vitro binding of dsRNA to the N-termi-
nal domains of the NS1A and NS1B proteins is well
established (Hatada and Fukuda, 1992; Lu et al., 1995;
Wang et al., 1999; present study), the specific function of
this dsRNA binding during virus infection remains elu-
sive. Because these two NS1 proteins bind dsRNA with
low affinity, approximately 5000-fold lower than the
dsRBDs found in cellular proteins (Kim et al., 1994; Lai et
al., 1995; McCormack and Samuel, 1995; Schmedt et al.,
1995; Wang et al., 1999; Ohman et al., 2000; Tian and
Mathews, 2001; present study), the NS1 proteins are at a
distinct disadvantage in competing with these cellular
proteins for dsRNA. The report that the NS1A protein in
influenza A virus-infected cells prevents the activation of
the cellular IRF-3 transcription factor by sequestering
dsRNA (Talon et al., 2000) is in conflict with a later study
showing that IRF-3 is in fact activated and functions in
the IFN-/-independent transcription of cellular antiviral
genes during infection by either influenza A or influenza
B virus (Kim et al., 2002). In addition, the report that the
NS1A protein in influenza A virus infected cells prevents
the activation of the cellular NF-B transcription factor by
sequestering dsRNA (Wang et al., 2000) is in conflict with
other studies showing that NF-B is activated in cells
infected by influenza A virus (Pahl and Baeuerle, 1995;
Ronni et al., 1997; Flory et al., 2000; Hiscott et al., 2001).
Further, many other studies have provided evidence that
IRF-3 and NF-B are activated during influenza A virus
infection: IFN-/ is produced in cells infected by influ-
enza A virus, as extensively documented since 1957
(Issacs and Lindemann,1957; Ronni et al., 1997; Huang et
al., 2001; Julkunen et al., 2001); and transcription of the
IFN- gene requires activated IRF-3 and NF-B (Maniatis
et al., 1998; Wathelet et al., 1998). Finally, it is not known
whether the inhibition of protein kinase R (PKR) activa-
tion by the NS1A protein (Hatada et al., 1999; Bergmann
et al., 2000) is mediated by its RNA-binding domain. In
fact, the amino acids of the NS1A protein that have been
implicated in the inhibition of PKR do not include those
that bind directly to the dsRNA target (R38, K41) nor those
that are required for the dimerization of the RNA-binding
domain, but instead include an amino acid in the effector
domain (Hatada et al., 1999). Consequently, it is not yet
known what function during infection is mediated by the
dsRNA binding of the N-terminal domains of the influ-
enza virus NS1A and NS1B proteins.
MATERIALS AND METHODS
Homology modeling
Using conformer 1 from the NMR solution structure of
NS1A(1-73) (Chien et al., 1997) (pdb id 1ns1), and the
sequence alignment of NS1A(1-73) with NS1B(1-93)
shown in Fig. 2A (Wang et al., 1999), a family of homology
models of NS1B(1-93) were generated by simulated an-
nealing and restrained torsion angle dynamics, using
computational techniques similar to those described
previously (Li et al., 1997; Sahasrabudhe et al., 1998). A
sequence alignment of the template protein NS1A(1-73)
and the target protein NS1B(1-93) was generated using
the BestFit algorithm of the GCG program (Wang et al.,
1999). Based on this alignment, “homologous” heavy (i.e.,
nonhydrogen) atoms in the two proteins were defined as
described elsewhere (Li et al., 1997; Sahasrabudhe et al.,
1998). Next, 10,000 distances between “homologous
atoms” were generated from the known three-dimen-
sional structure of the template protein. Approximately
one-third of these distances were randomly selected and
converted to upper and lower distance restraints for the
target protein by adding or subtracting 10% of the exact
interatomic distance in the template. These restraints
were employed in structure calculations using the
DYANA program (version 1.5) (Guntert et al., 1997). A total
of 20 structures were calculated using the standard sim-
ulated annealing protocol within DYANA, consisting of
4000 torsion angle dynamics steps followed by energy
minimization. The nine structures that best satisfy the
homology restraints, as judged by their target function
values (ranging from 0.6 to 6.1 units), were then defined
as an ensemble representing the predicted structure of
NS1B(1-93). Superpositions of atomic coordinates of
these nine structures (Fig. 3) demonstrate where the
homology modeling prediction is consistent and also
shows where the homology constraints are too sparse to
generate a consistent prediction. Within this ensemble of
conformers, the root-mean-squared deviation of back-
bone atom positions is 0.63 Å, for residues of the
NS1B(1-93) model which align with the six -helices of
NS1A(1-73). The ribbon representations of the NS1B(1-
93) homology model shown were generated using the
MOLMOL molecular graphics program (Koradi et al.,
1996).
Glutathione-Sepharose affinity selection
DNA encoding the mature form of the ISG15 protein
was cloned into pGEX-3X, and the GST-ISG15 fusion
protein was expressed and purified as previously de-
scribed (Qiu and Krug, 1994). GST-ISG15 was combined
with the indicated 35S-labeled protein synthesized in
vitro, and the mixture was subjected to glutathione-
Sepharose affinity selection (Nemeroff et al., 1995). To
prepare these labeled proteins, the DNA encoding the
wild-type or mutant NS1B(1-103) protein was cloned into
pGEM1 and translated using a TNT Coupled Transcrip-
tion/Translation kit (Promega) in the presence of [35S]me-
thionine. The mutations in the NS1B(1-103) proteins were
generated by PCR.
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RNA-binding and dimerization assays
The GST portion of all the GST fusion proteins used in
these assays was cleaved using the protease factor Xa.
To prepare the radiolabeled dsRNA target for the RNA-
binding assay, a 200-nucleotide-long globin cDNA se-
quence was inserted into a pGEM1 vector, and both
strands were transcribed using SP6 and T7 RNA poly-
merases in the presence of [-32P]UTP. The two comple-
mentary RNAs were then annealed to form the radiola-
beled dsRNA target. The indicated amount of the wild-
type or mutant NS1B(1-103) protein was mixed with the
radiolabeled dsRNA (50,000 cpm, 1.5 nM). Where indi-
cated, wild-type NS1B(1-103) protein was mixed with the
ISG15 protein (1:2 molar ratio) prior to the addition of the
dsRNA. RNA-binding reactions at 0°C, and non-denatur-
ing electrophoresis to resolve RNA–protein complexes
from free RNA, were carried out as described previously
(Wang et al., 1999). To assay for dimerization, the indi-
cated wild-type or mutant NS1B(17103) protein was
treated with 0.01% (v/v) glutaraldehyde, and the samples
were then resolved on a 12% SDS–polyacrylamide gel,
which was then immunoblotted with anti-NS1 antibody
(Nemeroff et al., 1995).
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